Ahmad O Khalifa1,2, Michael Kavran1, Amr Mahran1, Ilaha Isali1, Juliana Woda3, Chris A Flask4,5,6, Marc S Penn7, Adonis K Hijaz8. 1. Department of Urology, University Hospitals Cleveland Medical Center, Case Western Reserve University, 11100 Euclid Ave, Cleveland, OH, 44106, USA. 2. Department of Urology, Menoufia University, Shibin El Kom, Egypt. 3. Juventus Therapeutics, Cleveland, OH, USA. 4. Departments of Radiology, Case Western Reserve University, Cleveland, OH, USA. 5. Departments of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA. 6. Departments of Pediatrics, Case Western Reserve University, Cleveland, OH, USA. 7. Summa Health Heart and Vascular Institute, Akron, OH, USA. 8. Department of Urology, University Hospitals Cleveland Medical Center, Case Western Reserve University, 11100 Euclid Ave, Cleveland, OH, 44106, USA. Adonis.hijaz@uhhospitals.org.
Abstract
INTRODUCTION AND HYPOTHESIS: SDF-1 chemokine enhances tissue regeneration through stem cell chemotaxis, neovascularization and neuronal regeneration. We hypothesized that non-viral delivery of human plasmids that express SDF-1 (pSDF-1) may represent a novel regenerative therapy for stress urinary incontinence (SUI). METHODS: Seventy-six female rats underwent vaginal distention (VD). They were then divided into four groups according to treatment: pSDF-1 (n = 42), sham (n = 30), PBS (n = 1) and luciferase-tagged pSDF-1 (n = 3). Immediately after VD, the pSDF-1 group underwent immediate periurethral injection of pSDF-1, and the sham group received a vehicle injection followed by leak point pressure (LPP) measurement at the 4th, 7th and 14th days. Urogenital tissues were collected for histology. H&E and trichrome slides were analyzed for vascularity and collagen/muscle components of the sphincter. For the luciferase-tagged pSDF-1 group, bioluminescence scans (BLIs) were obtained on the 3rd, 7th and 14th days following injections. Statistical analysis was conducted using ANOVA with post hoc LSD tests. The Mann-Whitney U test was employed to make pair-wise comparisons between the treated and sham groups. We used IBM SPSS, version 22, for statistical analyses. RESULTS: BLI showed high expression of luciferase-tagged pSDF-1 in the pelvic area over time. VD resulted in a decline of LPP at the 4th day in both groups. The pSDF1-treated group demonstrated accelerated recovery that was significantly higher than that of the sham-treated group at the 7th day (22.64 cmH2O versus 13.99 cmH2O, p < 0.001). Functional improvement persisted until the 14th day (30.51 cmH2O versus 24.11 cmH2O, p = 0.067). Vascularity density in the pSDF-1-treated group was higher than in the sham group at the 7th and 14th days (p < 0.05). The muscle density/sphincter area increased significantly from the 4th to 14th day only in the pSDF-1 group. CONCLUSIONS: Periurethral injection of pSDF-1 after simulated childbirth accelerated the recovery of continence and regeneration of the urethral sphincter in a rat SUI model. This intervention can potentially be translated to the treatment of post-partum urinary incontinence.
INTRODUCTION AND HYPOTHESIS: SDF-1 chemokine enhances tissue regeneration through stem cell chemotaxis, neovascularization and neuronal regeneration. We hypothesized that non-viral delivery of human plasmids that express SDF-1 (pSDF-1) may represent a novel regenerative therapy for stress urinary incontinence (SUI). METHODS: Seventy-six female rats underwent vaginal distention (VD). They were then divided into four groups according to treatment: pSDF-1 (n = 42), sham (n = 30), PBS (n = 1) and luciferase-tagged pSDF-1 (n = 3). Immediately after VD, the pSDF-1 group underwent immediate periurethral injection of pSDF-1, and the sham group received a vehicle injection followed by leak point pressure (LPP) measurement at the 4th, 7th and 14th days. Urogenital tissues were collected for histology. H&E and trichrome slides were analyzed for vascularity and collagen/muscle components of the sphincter. For the luciferase-tagged pSDF-1 group, bioluminescence scans (BLIs) were obtained on the 3rd, 7th and 14th days following injections. Statistical analysis was conducted using ANOVA with post hoc LSD tests. The Mann-Whitney U test was employed to make pair-wise comparisons between the treated and sham groups. We used IBM SPSS, version 22, for statistical analyses. RESULTS: BLI showed high expression of luciferase-tagged pSDF-1 in the pelvic area over time. VD resulted in a decline of LPP at the 4th day in both groups. The pSDF1-treated group demonstrated accelerated recovery that was significantly higher than that of the sham-treated group at the 7th day (22.64 cmH2O versus 13.99 cmH2O, p < 0.001). Functional improvement persisted until the 14th day (30.51 cmH2O versus 24.11 cmH2O, p = 0.067). Vascularity density in the pSDF-1-treated group was higher than in the sham group at the 7th and 14th days (p < 0.05). The muscle density/sphincter area increased significantly from the 4th to 14th day only in the pSDF-1 group. CONCLUSIONS: Periurethral injection of pSDF-1 after simulated childbirth accelerated the recovery of continence and regeneration of the urethral sphincter in a rat SUI model. This intervention can potentially be translated to the treatment of post-partum urinary incontinence.
Authors: R V Abruzzese; D Godin; M Burcin; V Mehta; M French; Y Li; B W O'Malley; J L Nordstrom Journal: Hum Gene Ther Date: 1999-06-10 Impact factor: 5.695
Authors: Christopher R Chapple; Francisco Cruz; Xavier Deffieux; Alfredo L Milani; Salvador Arlandis; Walter Artibani; Ricarda M Bauer; Fiona Burkhard; Linda Cardozo; David Castro-Diaz; Jean Nicolas Cornu; Jan Deprest; Alfons Gunnemann; Maria Gyhagen; John Heesakkers; Heinz Koelbl; Sheila MacNeil; Gert Naumann; Jan-Paul W R Roovers; Stefano Salvatore; Karl-Dietrich Sievert; Tufan Tarcan; Frank Van der Aa; Francesco Montorsi; Manfred Wirth; Mohamed Abdel-Fattah Journal: Eur Urol Date: 2017-04-14 Impact factor: 20.096
Authors: Katherine Chapin; Ahmad Khalifa; Thomas Mbimba; Phillip McClellan; James Anderson; Yuri Novitsky; Adonis Hijaz; Ozan Akkus Journal: J Biomed Mater Res B Appl Biomater Date: 2018-06-13 Impact factor: 3.405
Authors: Ilaha Isali; Amr Mahran; Ahmad O Khalifa; David Sheyn; Mandy Neudecker; Arshna Qureshi; Britt Conroy; Fredrick R Schumacher; Adonis K Hijaz; Sherif A El-Nashar Journal: Int Urogynecol J Date: 2019-07-16 Impact factor: 2.894